13F Filings History of Meditor Group Ltd

Latest 13F report
Q3 2024 - 07 Oct 2024
Value $
$48,149,045
Signature - Title
Brian Desmond - Director, Meditor Group Limited
Location
Hamilton, Bermuda
Summary
This page shows a list of all the recent 13F filings made by Meditor Group Ltd. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Meditor Group Ltd reported 4 stock holdings with total value $48,149,045 as of Q3 2024. Top holdings included EXEL, ESPR, INDA, and EPI.

Notify me when Meditor Group Ltd files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2024 4 $48,149,045 $0 -$10,134,773 -$10,134,773 EXEL, ESPR, INDA, EPI 13F-HR 07 Oct 2024, 10:29
Q2 2024 4 $54,063,592 $0 -$10,017,126 -$10,017,126 EXEL, ESPR, INDA, EPI 13F-HR 22 Jul 2024, 09:05
Q1 2024 4 $68,048,528 $0 -$10,429,335 -$10,429,335 EXEL, ESPR, INDA, EPI 13F-HR 11 Apr 2024, 06:43
Q4 2023 4 $80,018,006 $0 -$11,992,601 -$11,992,601 EXEL, ESPR, INDA, EPI 13F-HR 04 Jan 2024, 09:25
Q3 2023 4 $77,143,738 $0 -$50,682,172 -$50,682,172 EXEL, ESPR, INDA, EPI 13F-HR 31 Oct 2023, 10:53
Q2 2023 4 $115,193,147 $0 -$9,289,184 -$9,289,184 EXEL, ESPR, INDA, EPI 13F-HR 25 Jul 2023, 12:47
Q1 2023 4 $125,546,800 $0 -$23,246,992 -$23,246,992 EXEL, ESPR, EPI, INDA 13F-HR 10 Apr 2023, 16:46
Q4 2022 4 $147,901,655 $0 -$3,386,269 -$3,386,269 EXEL, ESPR, INDA, EPI 13F-HR 04 Jan 2023, 17:42
Q3 2022 4 $150,330,000 $0 -$14,174,643 -$14,174,643 EXEL, ESPR, INDA, EPI 13F-HR 07 Nov 2022, 14:02
Q2 2022 4 $202,238,000 $0 -$26,316,374 -$26,316,374 EXEL, ESPR, INDA, EPI 13F-HR 18 Jul 2022, 14:45
Q1 2022 4 $239,737,000 $0 -$23,721,879 -$23,721,879 EXEL, ESPR, EPI, INDA 13F-HR 12 Apr 2022, 13:10
Q4 2021 4 $221,352,000 +$8,249,935 -$26,202,788 -$17,952,853 EXEL, ESPR, INDA, EPI 13F-HR 05 Jan 2022, 11:13
Q3 2021 4 $291,116,000 $0 $0 $0 EXEL, ESPR, INDA, EPI 13F-HR 14 Oct 2021, 16:24
Q2 2021 4 $282,629,000 +$2,939,832 -$10,138,877 -$7,199,045 EXEL, ESPR, INDA, EPI 13F-HR 12 Jul 2021, 10:25
Q1 2021 4 $355,996,000 $0 -$42,195,181 -$42,195,181 EXEL, ESPR, INDA, EPI 13F-HR 09 Apr 2021, 12:09
Q4 2020 5 $359,367,000 $0 -$7,558,080 -$7,558,080 EXEL, ESPR, INDA, ALKS, EPI 13F-HR 06 Jan 2021, 14:21
Q3 2020 5 $446,296,000 $0 -$2,558,000 -$2,558,000 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 19 Oct 2020, 12:09
Q2 2020 6 $476,775,000 $0 -$42,452,037 -$42,452,037 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 14 Jul 2020, 14:31
Q1 2020 6 $290,383,000 $0 -$8,480,272 -$8,480,272 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 30 Apr 2020, 14:57
Q4 2019 6 $350,575,000 $0 -$8,435,000 -$8,435,000 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 02 Jan 2020, 16:41
Q3 2019 9 $410,559,000 $0 $0 $0 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 31 Oct 2019, 13:09
Q2 2019 9 $497,155,000 $0 -$9,508,422 -$9,508,422 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 24 Jul 2019, 11:43
Q1 2019 9 $533,329,000 +$10,038,000 -$49,736,774 -$39,698,774 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 03 Apr 2019, 12:53
Q4 2018 6 $485,472,000 +$3,298,055 -$4,079,321 -$781,266 EXEL, ESPR, ALKS, INDA, EPI 13F-HR 02 Jan 2019, 12:23
Q3 2018 6 $465,250,000 $0 $0 $0 EXEL, ESPR, ALKS, EPI, INDA 13F-HR 09 Oct 2018, 09:43
Q2 2018 6 $511,974,000 +$1,591,110 $0 +$1,591,110 EXEL, ESPR, ALKS, EPI, INDA 13F-HR 19 Jul 2018, 13:23
Q1 2018 6 $635,754,000 +$19,268,674 -$38,402,966 -$19,134,292 EXEL, ESPR, ALKS, CLDX, EPI 13F-HR 20 Apr 2018, 13:06
Q4 2017 8 $776,915,000 +$1,836,931 -$28,335,840 -$26,498,909 EXEL, ESPR, ALKS, CLDX, SPXU 13F-HR 03 Jan 2018, 17:16
Q3 2017 8 $658,730,000 +$88,120,411 -$124,270,566 -$36,150,155 EXEL, ESPR, ALKS, CLDX, SPXU 13F-HR 17 Oct 2017, 09:25
Q2 2017 8 $664,599,000 +$56,042,616 $0 +$56,042,616 EXEL, ALKS, ESPR, SPXU, SDS 13F-HR 21 Jul 2017, 11:17
Q1 2017 7 $559,323,000 +$53,007,000 -$52,161,556 +$845,444 EXEL, ALKS, SPXU, SDS, EPI 13F-HR 24 Apr 2017, 11:39
Q4 2016 5 $405,188,000 $0 -$9,405,583 -$9,405,583 EXEL, ALKS, EPI, INDA, VVUS 13F-HR 01 Feb 2017, 14:23
Q3 2016 5 $361,173,000 $0 $0 $0 EXEL, ALKS, EPI, INDA, VVUS 13F-HR 27 Oct 2016, 12:16
Q2 2016 5 $245,633,000 +$26,929,000 -$257,600 +$26,671,400 EXEL, ALKS, EPI, INDA, VVUS 13F-HR 22 Jul 2016, 13:58
Q1 2016 3 $126,079,000 $0 -$1,731,862 -$1,731,862 EXEL, ALKS, VVUS 13F-HR 18 Apr 2016, 16:38
Q4 2015 4 $209,455,000 $0 -$434,287 -$434,287 EXEL, ALKS, VVUS, ITEK 13F-HR 22 Jan 2016, 14:34
Q3 2015 4 $189,626,000 +$17,310,014 $0 +$17,310,014 EXEL, ALKS, VVUS, ITEK 13F-HR 08 Oct 2015, 15:00
Q2 2015 3 $145,013,000 $0 $0 $0 EXEL, ALKS, VVUS 13F-HR 22 Jul 2015, 14:03
Q1 2015 3 $119,143,000 $0 $0 $0 ALKS, EXEL, VVUS 13F-HR 13 Apr 2015, 09:19
Q4 2014 3 $96,356,000 $0 $0 $0 ALKS, EXEL, VVUS 13F-HR 09 Feb 2015, 12:20
Q3 2014 3 $86,190,000 $0 -$734,823 -$734,823 ALKS, EXEL, VVUS 13F-HR 22 Oct 2014, 13:08
Q2 2014 3 $133,430,000 +$4,057,829 $0 +$4,057,829 EXEL, ALKS, VVUS 13F-HR 08 Jul 2014, 10:30
Q1 2014 3 $127,593,000 +$25,982,923 $0 +$25,982,923 EXEL, ALKS, VVUS 13F-HR 08 May 2014, 10:21
Q4 2013 3 $135,338,000 $0 $0 $0 EXEL, ALKS, VVUS 13F-HR 21 Jan 2014, 10:51